About
Overview
Management Team
Board of Directors
Clinical Advisors
Strategic Collaborations (MJFF)
Contact Us
Product Pipeline
APL-130277 Overview
APL-130277 Clinical Trials
APL-130277 Published Data
Parkinson's Disease
Overview
Treatment of Parkinson's Disease
OFF Episodes in Parkinson's Disease
Current Treatment of OFF Episodes
About Apomorphine
Parkinson's Resources
Investors
Company Information
News / Events
Financial Information
Stock Data / Analyst Coverage
SEC / OSC
Corporate Governance
PFIC Info
News
Press Releases
In The News
Careers
Investors
Company Info
Overview
Profile
Presentations
Management Team
Contacts
FAQ
News / Events
Overview
Press Releases
IR Calendar
Email Alerts
Financial Info
Financial Results
Stock Data / Analyst Coverage
Stock Data / Analyst Coverage
Quote: CYNA
Quote: CTH
SEC / OSC
SEC/EDGAR
Annual Reports
Quarterly Reports
OSC/SEDAR
Governance
Overview
Board of Directors
Board Committees
Governance Documents
PFIC Info
PFIC Statements
Investor Tools
Email Alerts
Tear Sheet
Contacts
RSS News Feed
SEC/EDGAR
Filter Filings:
View All
10-K
10-K/A
10-Q
144
144/A
8-A12B
8-K
CERTNAS
CT ORDER
D
D/A
EFFECT
F-10
F-10/A
F-X
FWP
S-8
SC 13D
SC 13G
SC 13G/A
SUPPL
Date
Form
Description
Docs
XBRL
Pages
02/22/16
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
12
02/16/16
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
10
02/05/16
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
12
02/04/16
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
16
02/03/16
8-K
Current report filing
Related Documents
EX-10.1
10
01/07/16
8-K
Current report filing
Related Documents
EX-99.1
8
01/04/16
8-K
Current report filing
Related Documents
EX-3.1
EX-99.1
12
12/17/15
CT ORDER
Confidential treatment order
1
12/15/15
8-K
Current report filing
3
12/14/15
144
Filing for proposed sale of securities under Rule 144
4
<< Previous
1
2
3
4
5
6
Next >>